Respiratory Syncytial Virus (RSV), common among young children, is surging in the U.S. and sparking concerns that hospitals could become overwhelmed this year by potential winter spikes in both the flu and COVID-19.

Data from the Centers for Disease Control and Prevention (CDC) shows that more than 4,000 cases of RSV are being reported each week.

RSV typically causes mild, cold-like symptoms that go away with moderate rest and self-care in healthy adults and older children, but younger children, especially those less than 6 months old, have the highest risk of developing severe cases that could lead to hospitalization.

There are currently no vaccines available for RSV, and the only treatment is monoclonal antibodies.

Read the full article here.